Cummings BS - Search Results

1

Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer.

Aljuffali IA, Mock JN, Costyn LJ, Nguyen H, Nagy T, Cummings BS, Arnold RD. Aljuffali IA, et al. Among authors: cummings bs. Cancer Biol Ther. 2011 Sep 1;12(5):407-20. doi: 10.4161/cbt.12.5.15950. Epub 2011 Sep 1. Cancer Biol Ther. 2011. PMID: 21709443 Free PMC article.

2

Inhibition of Ca2+-independent phospholipase A2 decreases prostate cancer cell growth by p53-dependent and independent mechanisms.

Sun B, Zhang X, Talathi S, Cummings BS. Sun B, et al. Among authors: cummings bs. J Pharmacol Exp Ther. 2008 Jul;326(1):59-68. doi: 10.1124/jpet.108.138958. Epub 2008 Apr 25. J Pharmacol Exp Ther. 2008. PMID: 18441250

3

Cellular and molecular mechanisms of bromate-induced cytotoxicity in human and rat kidney cells.

Zhang X, De Silva D, Sun B, Fisher J, Bull RJ, Cotruvo JA, Cummings BS. Zhang X, et al. Among authors: cummings bs. Toxicology. 2010 Feb 28;269(1):13-23. doi: 10.1016/j.tox.2010.01.002. Epub 2010 Jan 11. Toxicology. 2010. PMID: 20067818

4

Inhibition of calcium-independent phospholipase A2 activates p38 MAPK signaling pathways during cytostasis in prostate cancer cells.

Sun B, Zhang X, Yonz C, Cummings BS. Sun B, et al. Among authors: cummings bs. Biochem Pharmacol. 2010 Jun 15;79(12):1727-35. doi: 10.1016/j.bcp.2010.02.005. Epub 2010 Feb 18. Biochem Pharmacol. 2010. PMID: 20171194

5

Secretory phospholipase A₂ responsive liposomes.

Zhu G, Mock JN, Aljuffali I, Cummings BS, Arnold RD. Zhu G, et al. Among authors: cummings bs. J Pharm Sci. 2011 Aug;100(8):3146-3159. doi: 10.1002/jps.22530. Epub 2011 Mar 31. J Pharm Sci. 2011. PMID: 21455978 Free PMC article.

6

Synthesis of lipids for development of multifunctional lipid-based drug-carriers.

Zhu G, Alhamhoom Y, Cummings BS, Arnold RD. Zhu G, et al. Among authors: cummings bs. Bioorg Med Chem Lett. 2011 Nov 1;21(21):6370-5. doi: 10.1016/j.bmcl.2011.08.103. Epub 2011 Sep 8. Bioorg Med Chem Lett. 2011. PMID: 21955941 Free PMC article.

7

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

Mock JN, Taliaferro JP, Lu X, Patel SK, Cummings BS, Long TE. Mock JN, et al. Among authors: cummings bs. Bioorg Med Chem Lett. 2012 Jul 15;22(14):4854-8. doi: 10.1016/j.bmcl.2012.05.038. Epub 2012 May 17. Bioorg Med Chem Lett. 2012. PMID: 22677312 Free PMC article.

8

Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.

Mock JN, Costyn LJ, Wilding SL, Arnold RD, Cummings BS. Mock JN, et al. Among authors: cummings bs. Integr Biol (Camb). 2013 Jan;5(1):172-82. doi: 10.1039/c2ib20108a. Integr Biol (Camb). 2013. PMID: 22890797 Free PMC article.

9

Association of brominated proteins and changes in protein expression in the rat kidney with subcarcinogenic to carcinogenic doses of bromate.

Kolisetty N, Bull RJ, Muralidhara S, Costyn LJ, Delker DA, Guo Z, Cotruvo JA, Fisher JW, Cummings BS. Kolisetty N, et al. Among authors: cummings bs. Toxicol Appl Pharmacol. 2013 Oct 15;272(2):391-8. doi: 10.1016/j.taap.2013.06.018. Epub 2013 Jun 26. Toxicol Appl Pharmacol. 2013. PMID: 23811332

10

Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease.

Quach ND, Arnold RD, Cummings BS. Quach ND, et al. Among authors: cummings bs. Biochem Pharmacol. 2014 Aug 15;90(4):338-48. doi: 10.1016/j.bcp.2014.05.022. Epub 2014 Jun 4. Biochem Pharmacol. 2014. PMID: 24907600 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters